Oyler John

Chief Executive Officer, DirectorBeOne Medicines Ltd. (ONC) · full profile →Form 4 · filed Jul 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$20.2M
Net Open-Market Flow
-$20.2M
Transactions
11
10 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 17, 2026Option exercise(M)65K$119.96$7.8M65K
Jul 17, 2026Sell(S)1K$305.20$439K63K
Jul 17, 2026Sell(S)597$306.96$183K63K
Jul 17, 2026Sell(S)680$309.05$210K62K
Jul 17, 2026Sell(S)5K$310.37$1.5M57K
Jul 17, 2026Sell(S)6K$311.42$1.7M52K
Jul 17, 2026Sell(S)36K$312.17$11.2M16K
Jul 17, 2026Sell(S)15K$313.19$4.7M791
Jul 17, 2026Sell(S)740$314.32$233K51
Jul 17, 2026Sell(S)51$315.06$16K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 17, 2026Option exercise(M)840K$0442K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001042047-26-000015) within minutes of acceptance. Every field above traces to the original document. Verify it directly: